ABCB1 and Parkinson disease: P-glycoprotein, which is a critical cellular defense mechanism against neurotoxicant accumulation in the brain (Zhao et al., 2015), has been shown via positron emission tomography (PET) imaging to exhibit reduced activity in the midbrain of patients with PD, which is indicative of BBB dysfunction (Kortekaas et al., 2005).